Humira (Adalimumab) Pregnancy Exposure Registry: OTIS Rheumatoid Arthritis in Pregnancy Project
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
- 22 Mar 2017 Planned End Date changed from 1 Feb 2017 to 1 Apr 2017.
- 27 Jan 2016 Planned End Date changed from 1 Jun 2016 to 1 Feb 2017 as reported by ClinicalTrials.gov record.